Autoantibodies and infection with SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies

Jan Damoiseaux*, Arad Dotan, Marvin J Fritzler, Dimitrios P Bogdanos, Pier Luigi Meroni, Dirk Roggenbuck, Michel Goldman, Nils Landegren, Paul Bastard, Yehuda Shoenfeld, Karsten Conrad

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

36 Citations (Web of Science)


The relation between infections and autoimmune diseases has been extensively investigated. Multiple studies suggest a causal relation between these two entities with molecular mimicry, hyperstimulation and dysregulation of the immune system as plausible mechanisms. The recent pandemic with a new virus, i.e., SARS-CoV-2, has resulted in numerous studies addressing the potential of this virus to induce autoimmunity and, eventually, autoimmune disease. In addition, it has also revealed that pre-existing auto-immunity (auto-Abs neutralizing type I IFNs) could cause life-threatening disease. Therefore, the topic of the 15th Dresden Symposium on Autoantibodies was focused on autoimmunity in the SARS-CoV-2 era. This report is a collection and distillation of the topics presented at this meeting.

Original languageEnglish
Article number103012
Number of pages8
JournalAutoimmunity Reviews
Issue number3
Early online date9 Dec 2021
Publication statusPublished - Mar 2022


  • Anti-IFNa
  • Antiphospholipid syndrome
  • Autoantibodies
  • Autoimmunity
  • COVID-19
  • MIS-C
  • Molecular mimicry
  • SARS-CoV-2

Cite this